MENU
TSHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Taysha Gene Therapies (TSHA) Ownership - Who owns Taysha Gene Therapies?

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more

Profile

Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.62B
P/E Ratio
2.70
Total Cash
297.34M
Projected Growth
N/A
Total Debt
69.03M
Revenue
6.31M
Risk (Beta)
-0.04
Dividend Yield
N/A
Total Cash/Share
1.09
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

TSHA
Capitalization
1.62B
P/E Ratio
2.70
Risk (Beta)
-0.04
Dividend Yield
N/A
Total Cash
297M
Total Cash/Share
1.09
Total Debt
69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
6.31M
ROE
N/A
Book Value
219M
P/B Ratio
7.39
Cash Flow
N/A
Earnings
-0.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
10.48
Current Revenue Per Employee
27205.48
Dividends Per Share - Security
N/A
EBITDA
-98.71M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.23
Shares Held By Institutions
1.13B
Shares Outstanding - Current
274M
Total Liabilities
97.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
241.618
View a ticker or compare two or three
TSHA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TSHA showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com